Kagimoto N, Masubuchi Y, Fujita S, Narimatsu S, Suzuki T
Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Chiba University, Japan.
J Pharm Pharmacol. 1994 Jun;46(6):528-30. doi: 10.1111/j.2042-7158.1994.tb03846.x.
The effect of repetitive oral administration of propranolol (100 mg kg-1 day-1, 5 days) on the kinetics of liver microsomal propranolol metabolism was investigated in the rat. Vmax values of the high-affinity phase for biphasic kinetics of propranolol 4- and 5-hydroxylase activities were decreased by propranolol pretreatment, while those of the low-affinity phase were unchanged. The Vmax value of monophasic 7-hydroxylase activity was also decreased. On the other hand, the Vmax value of N-desisopropylase activity in the propranolol-treated rats was increased more than 2-fold compared with non-treated (control) rats, resulting in a change from monophasic in control rats to biphasic kinetics in propranolol-treated rats. These findings indicate that repetitive administration of propranolol selectively impairs a CYP2D isozyme that is involved in the high-affinity phases for propranolol ring-hydroxylations.
在大鼠中研究了重复口服普萘洛尔(100 mg kg-1 天-1,共5天)对肝脏微粒体普萘洛尔代谢动力学的影响。普萘洛尔预处理降低了普萘洛尔4-羟化酶和5-羟化酶活性双相动力学高亲和力阶段的Vmax值,而低亲和力阶段的Vmax值未改变。单相7-羟化酶活性的Vmax值也降低了。另一方面,与未处理(对照)大鼠相比,普萘洛尔处理大鼠的N-去异丙基酶活性的Vmax值增加了2倍以上,导致对照大鼠的单相动力学转变为普萘洛尔处理大鼠的双相动力学。这些发现表明,重复给药普萘洛尔会选择性损害参与普萘洛尔环羟化高亲和力阶段的CYP2D同工酶。